Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Mallinckrodt
McKesson
Accenture
Daiichi Sankyo
Cipla
Farmers Insurance
Healthtrust
UBS

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050299

« Back to Dashboard

NDA 050299 describes NILSTAT, which is a drug marketed by Lederle, Dava Pharms Inc, and Glenmark Generics, and is included in six NDAs. Additional details are available on the NILSTAT profile page.

The generic ingredient in NILSTAT is nystatin. There are eight drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the nystatin profile page.
Summary for 050299
Tradename:NILSTAT
Applicant:Glenmark Generics
Ingredient:nystatin
Patents:0
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 050299

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION;ORALStrength100,000 UNITS/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Accenture
Fish and Richardson
Harvard Business School
Dow
McKesson
Cerilliant
Daiichi Sankyo
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.